Results 121 to 130 of about 33,934 (313)

A cost‐effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Effective weight management pharmacotherapies are a new alternative to bariatric surgery or health behaviour intervention (HBI) alone. Comparative cost‐effectiveness evaluations can guide decision‐making. We aimed to evaluate the cost‐effectiveness of sleeve gastrectomy (SG), Roux‐en‐Y gastric bypass (RYGB), semaglutide, tirzepatide, and ...
Nisha Gupta   +5 more
wiley   +1 more source

Obesity Surgery: Quality of Life and Psychological Variables before and after Surgical Treatment

open access: yesPsicologia, 2009
It is urgent to understand if obesity surgery (gastrobandoplasty and gastric bypass) has repercussion in psychological domain, eating behaviour and quality of life of patients submitted to it.
Isabel Silva   +2 more
doaj  

Management of Complex Silastic Ring Erosion Following Roux‐en‐Y Gastric Bypass

open access: yes
ANZ Journal of Surgery, EarlyView.
Preekesh Suresh Patel, Michael Booth
wiley   +1 more source

Higher plasma dicarbonyl levels are associated with liver fibrosis in obese individuals

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Introduction Methylglyoxal (MGO) is a very reactive compound that modifies proteins, forming advanced glycation end products (AGEs) and activating inflammatory pathways. Elevated MGO levels have been linked to various diseases, including type 2 diabetes and atherosclerosis. However, the role of MGO and other glycating agents in the progression
Oluwatomisono I. Akinrimisi   +12 more
wiley   +1 more source

SELENIUM DEFICIENCY INDUCED CARDIOMYOPATHY IN A PATIENT WITH A HISTORY OF GASTRIC BYPASS SURGERY [PDF]

open access: bronze, 2008
Mayuko Ito Fukunaga   +4 more
openalex   +1 more source

Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery [PDF]

open access: green, 2008
David B. Sarwer   +6 more
openalex   +1 more source

Differential effects of bariatric surgery on circulating GDF15 and FGF21 levels: Implications for glycemic status and weight loss outcomes

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Our research shows different post‐surgical patters in GDF15 and FGF21 concentrations following Roux‐en‐Y gastric bypass. GDF15 levels increase significantly in patients with obesity and normoglycemia and in those with obesity and impaired glucose tolerance or type 2 diabetes, while FGF21 concentrations significantly decrease in patients with obesity ...
Laura Salmón‐Gómez   +12 more
wiley   +1 more source

Fatal Hyperammonemic Encephalopathy After Gastric Bypass Surgery [PDF]

open access: bronze, 2008
Andrew Z. Fenves   +4 more
openalex   +1 more source

Effects of vatinoxan on gastrointestinal motility, sedation, and antinociception during and after long‐lasting detomidine infusion in horses

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Sedation in horses is typically achieved using alpha‐2 adrenoceptor agonists, although their use is associated with multiple side effects. A peripheral alpha‐2 adrenoceptor antagonist, vatinoxan, can alleviate many of these. Objectives To evaluate the effects of vatinoxan infusion on gastrointestinal motility, sedation, and ...
Bartlomiej Obrochta   +7 more
wiley   +1 more source

Fatal Fulminant Pancreatitis After Laparoscopic Gastric Bypass Surgery [PDF]

open access: bronze, 2008
Cunchuan Wang   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy